What Happened?
Penn Valley, PA-based Renovacor Appointed Magdalene Cook as President and Chief Executive Officer
About the Company
Renovacor is a preclinical gene therapy company developing a pipeline of innovative and proprietary AAV based gene therapies for BAG3 gene mutation-associated diseases in areas of high unmet medical need. Renovacor`s therapeutic focus is initially on cardiovascular disease, with a lead program in BAG3 mutation-associated dilated cardiomyopathy.
About the Person
Magdalene Cook is President and Chief Executive Officer at Renovacor. Previously, Magdalene held various senior HR leadership roles in the industry.
Info Source
News
Short Profile